Literature DB >> 12609504

Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle.

John D Porter1, Wei Guo, Anita P Merriam, Sangeeta Khanna, Georgiana Cheng, Xiaohua Zhou, Francisco H Andrade, Chellah Richmonds, Henry J Kaminski.   

Abstract

Prior studies and the efficacy of immunotherapies provide evidence that inflammation is mechanistic in pathogenesis of Duchenne muscular dystrophy. To identify putative pro-inflammatory mechanisms, we evaluated chemokine gene/protein expression patterns in skeletal muscle of mdx mice. By DNA microarray, reverse transcription-polymerase chain reaction, quantitative polymerase chain reaction, and immunoblotting, convergent evidence established the induction of six distinct CC class chemokine ligands in adult MDX: CCL2/MCP-1, CCL5/RANTES, CCL6/mu C10, CCL7/MCP-3, CCL8/MCP-2, and CCL9/MIP-1gamma. CCL receptors, CCR2, CCR1, and CCR5, also showed increased expression in mdx muscle. CCL2 and CCL6 were localized to both monocular cells and muscle fibers, suggesting that dystrophic muscle may contribute toward chemotaxis. Temporal patterns of CCL2 and CCL6 showed early induction and maintained expression in mdx limb muscle. These data raise the possibility that chemokine signaling pathways coordinate a spatially and temporally discrete immune response that may contribute toward muscular dystrophy. The chemokine pro-inflammatory pathways described here in mdx may represent new targets for treatment of Duchenne muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12609504     DOI: 10.1016/s0960-8966(02)00242-0

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  40 in total

1.  Chemokine expression and control of muscle cell migration during myogenesis.

Authors:  Christine A Griffin; Luciano H Apponi; Kimberly K Long; Grace K Pavlath
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

2.  Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle.

Authors:  J P Gomez; C Gonçalves; C Pichon; P Midoux
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

3.  Disease-modifying bioactivity of intravenous cardiosphere-derived cells and exosomes in mdx mice.

Authors:  Russell G Rogers; Mario Fournier; Lizbeth Sanchez; Ahmed G Ibrahim; Mark A Aminzadeh; Michael I Lewis; Eduardo Marbán
Journal:  JCI Insight       Date:  2019-04-04

4.  Targeting latent TGFβ release in muscular dystrophy.

Authors:  Ermelinda Ceco; Sasha Bogdanovich; Brandon Gardner; Tamari Miller; Adam DeJesus; Judy U Earley; Michele Hadhazy; Lucas R Smith; Elisabeth R Barton; Jeffery D Molkentin; Elizabeth M McNally
Journal:  Sci Transl Med       Date:  2014-10-22       Impact factor: 17.956

5.  Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin.

Authors:  John H Boyd; Maziar Divangahi; Linda Yahiaoui; Dusanka Gvozdic; Salman Qureshi; Basil J Petrof
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

6.  Differential coupling of Arg- and Gly389 polymorphic forms of the beta1-adrenergic receptor leads to pathogenic cardiac gene regulatory programs.

Authors:  Steven M Swift; Brigitte R Gaume; Kersten M Small; Bruce J Aronow; Stephen B Liggett
Journal:  Physiol Genomics       Date:  2008-07-29       Impact factor: 3.107

7.  CC family chemokines directly regulate myoblast responses to skeletal muscle injury.

Authors:  Linda Yahiaoui; Dusanka Gvozdic; Gawiyou Danialou; Matthias Mack; Basil J Petrof
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

8.  The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activity.

Authors:  Miriam Bobadilla; Neira Sainz; Gloria Abizanda; Josune Orbe; José Antonio Rodriguez; José Antonio Páramo; Felipe Prósper; Ana Pérez-Ruiz
Journal:  Stem Cells Dev       Date:  2014-03-14       Impact factor: 3.272

Review 9.  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Authors:  Nicholas P Evans; Sarah A Misyak; John L Robertson; Josep Bassaganya-Riera; Robert W Grange
Journal:  PM R       Date:  2009-08       Impact factor: 2.298

10.  Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.

Authors:  Ju Lan Chun; Robert O'Brien; Min Ho Song; Blake F Wondrasch; Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2012-12-27       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.